Jevtana (Cabazitaxel)
Generic Durag Name: 
Brand Name: 
Anti Cancer Medicine
Enquiry Now
Product Description: 
Cabazitaxel is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
Speciality Pharma | eCare Softech Pvt Ltd